It has been previously suggested that tyrosine phosphorylation of p62,
p68, and p130 might be necessary for the platelet shape change to occ
ur. In preliminary studies we observed that high concentrations (30 mu
M) of a protein kinase C inhibitor, Ro 31-8220, selectively suppresse
d p130 tyrosine phosphorylation induced by thrombin, the thromboxane s
ynthetic analogue (U46619) and ADP. Therefore, we have investigated th
e correlation, if any, between p130 tyrosine phosphorylation and plate
let shape change induced by the same agonists in the presence of Ro 31
-8220. Our results demonstrated that high concentrations of this compo
und almost completely abolished p130 tyrosine phosphorylation, whereas
they had no effect on platelet shape change, thus proving a dissociat
ion between these two phenomena. Our data support the hypothesis that
a role in platelet shape change might be played by tyrosine phosphoryl
ation of proteins other than p130. (C) 1998 Elsevier Science Ltd.